Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 175 publications
A reasonably likely surrogate endpoint for metabolic dysfunction-associated steatohepatitis.
Journal: Nature medicine
Published: April 28, 2026
Assessment of Esophageal and Gastric Varices in Patients With Cirrhosis for Clinical Trials: A Centralized Blinded Evaluation System.
Journal: Gastro hep advances
Published: April 20, 2026
An itch finally addressed: linerixibat and the promise of targeted antipruritic therapy in primary biliary cholangitis.
Journal: Translational gastroenterology and hepatology
Published: March 31, 2026
Efficacy and safety of belapectin for the prevention of esophageal varices in patients with MASH cirrhosis: The randomized, placebo-controlled NAVIGATE trial.
Journal: Hepatology (Baltimore, Md.)
Published: February 25, 2026
Beyond Hy's Law: Importance of Markedly Elevated Aminotransferases without Hyperbilirubinemia.
Journal: Clinical pharmacology and therapeutics
Published: February 12, 2026
Global Longitudinal Assessment of MASLD Using Magnetic Resonance Elastography (GOLDMINE): A Multi-Center, International Prospective Cohort Study of Imaging Biomarkers in MASLD Clinical Outcomes.
Journal: Alimentary pharmacology & therapeutics
Published: February 02, 2026
Letter on: 'Impact of Frailty on the Prognosis of Patients With Liver Cirrhosis Undergoing Insertion of a TIPS'.
Journal: Alimentary pharmacology & therapeutics
Published: January 13, 2026
New Lessons in Drug-Induced Liver Injury: Rising Hepatotoxicity of Oncologic Agents and Predicting Very Short-Term Survival in Drug-Induced Liver Injury Liver Failure.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: December 29, 2025
Inpatient Telehepatology at Community Hospitals: Expanding Access and Comanaging Complex Care.
Journal: NEJM catalyst innovations in care delivery
Published: December 18, 2025
Clinical Trial: Semaglutide Versus Placebo in NIT-Assessed MASH-A Multicenter Randomised Placebo-Controlled Trial (SAMARA).
Journal: Alimentary pharmacology & therapeutics
Published: November 03, 2025
Low Albumin and Elevated FIB-4 Are Associated With Adverse Outcomes After the Fontan Procedure.
Journal: Heart, lung & circulation
Published: October 28, 2025
Last Updated: 09/26/2026